Compare AENT & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AENT | IPSC |
|---|---|---|
| Founded | 1990 | 2019 |
| Country | United States | United States |
| Employees | 697 | N/A |
| Industry | Durable Goods | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 370.0M | 413.0M |
| IPO Year | N/A | 2021 |
| Metric | AENT | IPSC |
|---|---|---|
| Price | $7.20 | $2.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $10.00 | $4.25 |
| AVG Volume (30 Days) | 15.5K | ★ 843.0K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $109,164,000.00 |
| Revenue This Year | $3.44 | N/A |
| Revenue Next Year | $1.64 | N/A |
| P/E Ratio | $11.23 | ★ N/A |
| Revenue Growth | N/A | ★ 1556.76 |
| 52 Week Low | $2.37 | $0.44 |
| 52 Week High | $8.80 | $2.97 |
| Indicator | AENT | IPSC |
|---|---|---|
| Relative Strength Index (RSI) | 48.02 | 50.99 |
| Support Level | $7.11 | $2.15 |
| Resistance Level | $7.41 | $2.42 |
| Average True Range (ATR) | 0.39 | 0.12 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 15.79 | 55.00 |
Alliance Entertainment Holding Corp is a distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world. The company has two divisions: Alliance Home Entertainment, which offers full-service support across production, marketing, and retail execution. and Alliance Authentic, which focuses on licensed collectibles and branded merchandise, including partnerships with Handmade by Robots, Master Replicas, and Weta Workshop.
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.